TLPH Stock Analysis: Buy, Sell, or Hold?
TLPH - Talphera, Inc. Common Stock
$0.96
-0.02 (-1.85%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When TLPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TLPH shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: TLPH shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TLPH is currently trading at $0.96, which is considered oversold relative to its 30-day fair value range of $0.98 to $1.14.
Technical Outlook: Technically, TLPH is showing sideways momentum. The price is currently testing key support at $0.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TLPH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+240.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TLPH is showing sideways momentum. The price is currently testing key support at $0.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TLPH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+240.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.98 -
$1.14
Company Quality Score
49/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 240.0% below Wall St target ($3.25)
Fair Price Analysis
30-Day Fair Range
$0.98 -
$1.14
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.16
(17.1%)
Support & Resistance Levels
Support Level
$0.93
Resistance Level
$1.04
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-3.30
Wall Street Target
$3.25
(+240.0%)
Last updated: February 01, 2026 2:42 AM ET
Data refreshes hourly during market hours. Next update: 3:42 AM
Data refreshes hourly during market hours. Next update: 3:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced TLPH Option Strategies
Professional options setups generated by AI based on today's TLPH price and gamma walls.
